Skip to main content
. 2017 Jun 13;9(5):403–409. doi: 10.4168/aair.2017.9.5.403

Table 2. General characteristics of the AR(Eos), AR(Neu1), and AR(Neu2) groups.

Characteristics AR(Eos) AR(Neu1) AR(Neu2)
No. 22 22 22
Gender (male) 12 (54.55) 16 (72.73) 17 (77.27)
Age (year) 15.59±11.53 15.86±13.31 15.82±12.24
History (year) 2.83±2.09 3.08±2.29 3.13±2.45
Asthma (%) 2 (9.10) 3 (13.64) 2 (9.10)
VAS 59.72±20.68 58.32±26.64 59.91±24.10
Nasal blockage* 2.22±0.73 1.64±0.85 1.59±0.80
Nasal itching 1.67±0.84 1.59±0.80 1.55±0.60
Nasal secretion 1.72±0.75 1.73±0.83 1.77±0.75
Sneezing 1.78±0.65 1.68±0.72 1.68±0.84
Total score 7.39±2.03 6.64±2.17 6.59±2.04
Eos % 91.01±13.36 4.73±4.15 3.86±4.08
Neu % 8.99±13.36 95.27±4.15 96.14±4.08
Inflammation cell grades 3.05±0.58 3.14±0.77 3.23±0.75

Data are shown as mean±SD or number (%).

AR, allergic rhinitis; VAS, visual analog scale; SD, standard deviation.

*The score of AR(Eos) was higher than that of AR(Neu1) (P=0.014) and AR(Neu2) (P=0.048).